AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

PMVP · NASDAQ · Biotechnology

PMV Pharmaceuticals

Develops a precision-oncology therapy for cancers with TP53 Y220C mutations.

$0.9846

Pre-market−0.23 (−18.63%)

At close$1.21(−0.82%)

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions70 holders · as of Mar 31, 2026	69.14%	36.96M shares
Insiders4 holders · as of Oct 29, 2025	1.31%	699.9K shares
Strategic holders1 holder · as of Feb 4, 2022	4.75%	2.54M shares
Otherremainder	24.80%	13.26M shares

53.46M company shares as of Sep 1, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
BML Capital Management, LLCInstitution	9.95%	5.32M	13Fas of Mar 31, 2026
BML Investment Partners, L.P.Institution	9.90%	5.29M	13Gfiled Feb 9, 2026 ↗
Tang Capital Management LLCInstitution	7.94%	4.25M	13Fas of Mar 31, 2026
Sio Capital Management, LLCInstitution	5.76%	3.08M	13Fas of Mar 31, 2026
Arrowmark Colorado Holdings LLCInstitution	5.37%	2.87M	13Fas of Mar 31, 2026
The Vanguard GroupInstitution	4.95%	2.65M	13D/Gfiled Feb 10, 2022 ↗
Euclidean Capital LLCInstitution	4.92%	2.63M	13Fas of Mar 31, 2026
BlackRock, Inc.Strategic	4.75%	2.54M	13D/Gfiled Feb 4, 2022 ↗
Eversept Partners, LPInstitution	4.39%	2.35M	13Fas of Mar 31, 2026
Acadian Asset Management LLCInstitution	4.15%	2.22M	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	3.69%	1.97M	13Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution	3.53%	1.88M	13Fas of Mar 31, 2026
Adage Capital Partners GP, L.L.C.Institution	3.48%	1.86M	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	1.64%	874,374	13Fas of Mar 31, 2026
Morgan StanleyInstitution	1.62%	864,311	13Fas of Mar 31, 2026
Stonepine Capital Management, LLCInstitution	1.32%	708,102	13Fas of Mar 31, 2026
Longaeva Partners L.P.Institution	1.03%	552,027	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.93%	495,922	13Fas of Mar 31, 2026
Aldebaran Capital, LLCInstitution	0.89%	473,362	13Fas of Mar 31, 2026
David Henry MackInsiderdirector, officer: President and CEO	0.84%	451,109	Form 4filed Oct 29, 2025 ↗
Marshall Wace, LLPInstitution	0.81%	434,093	13Fas of Mar 31, 2026
Bridgeway Capital Management, LLCInstitution	0.80%	428,853	13Fas of Mar 31, 2026
Assenagon Asset Management S.A.Institution	0.67%	360,786	13Fas of Mar 31, 2026
Walleye Capital LLCInstitution	0.63%	335,694	13Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution	0.56%	298,126	13Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

70 holders · 36.96M shares · 16 new positions · 32 increased · 19 reduced · 9 closed

Holder	Shares	% outstanding	Chg q/q	Filed
BML Capital Management, LLC	5.32M	9.95%	+28.0K	May 6, 2026
Tang Capital Management LLC	4.25M	7.94%	−694.9K	May 15, 2026
Sio Capital Management, LLC	3.08M	5.76%	+440.0K	May 14, 2026
Arrowmark Colorado Holdings LLC	2.87M	5.37%	−217.3K	May 15, 2026
Euclidean Capital LLC	2.63M	4.92%	0	May 15, 2026
Eversept Partners, LP	2.35M	4.39%	+2.35Mnew	May 15, 2026
Acadian Asset Management LLC	2.22M	4.15%	+200.1K	May 13, 2026
Vanguard Capital Management LLC	1.97M	3.69%	+1.97Mnew	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
BML Investment Partners, L.P.	9.90%	5.29M	13G	Feb 9, 2026 ↗
Tang Capital Management, LLC	8.90%	4.72M	13G	Sep 23, 2025 ↗
ArrowMark Colorado Holdings, LLC	5.81%	3.09M	13G	Feb 17, 2026 ↗
Sio Capital Management, LLC	5.77%	3.08M	13G	May 4, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Oct 23, 2025	Orbimed Advisors LLC10 percent owner	Sale	1,000,000	$1.52	4,975,291
Sep 10, 2025	Orbimed Advisors LLC10 percent owner	Sale	500,000	$1.80	5,975,291

CongressHouse and Senate disclosures

Not reported.